Embed Size (px)
Citation preview
China Sinopharm International Corporation
— 2 —
China National Pharmaceutical Group
Corporation(Sinopharm)is the largest
medical and healthcare group
Background
11 wholly-owned or share-holding
subsidiaries, 6 listed companies.
Subsidiaries
USD 40 Billion in 2014
Revenue
The only pharmaceutical group in
China listed in Fortune’s Global 500,
(276th in 2015).
Achievement
— 3 —
11 Wholly-Owned or Holding Subsidiaries
China Sinopharm International Corporation
China National Pharmaceutical Industry Corporation
China National Biotec Group Co., Ltd.
Sinopharm Group (Holding) Co., Ltd.
Reed Sinopharm Exhibitions Co., Ltd.
China National Scientific Instruments & Materials
Corporation
China National Group Corporation of Traditional
and Herbal Medicine
Sinopharm Group Finance Co.,Ltd
Sinopharm Yangzhou VAC Biological Engineering Co., Ltd.
China State Institute of Pharmaceutical Industry
Sino Pharmengin Corporation
— 4 —
Sinopharm Group (Holding) Co., Ltd.
China National Medicines Co., Ltd.
Sinopharm Accord Pharmaceutical Co., Ltd.
Beijing Tiantan Biological Products Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd.
China Traditional Chinese Medicine Co., Ltd.
6 Listed Companies
China Sinopharm International Corporation (Sinopharm International) is the wholly-owned subsidiary of Sinopharm, shoulders the strategic mission of developing International Pharmaceutical Business, Medical and Health industry for Sinopharm.
In 2014, the total sales revenue of Sinopharm International reached over USD 2.5 billion with the total Imp & Exp volume exceeded USD 1.5 billion. Sinopharm International is among the top 5 companies in China in the Imp & Exp of Medical and Healthcare products.
— 6 —
The Whole Industry Chain of Export Project
International Pharmaceutical Trade
International Medical Cooperation
Medical and Healthcare Services
Sinopharm International——Main Business
— 7 —
INTEGRATED
MEDICAL
LOOP
Sinopharm International——Double Closed Loops
Training
Hospital
Management
Engineering-
Procurement-
Construction
Equipment
Supply and
Maintenance
INTEGRATED
PHARMACEUTICAL
LOOP
Factory
Operating
Product
Buyback
Engineering-
Procurement-
Construction
Equipment
Supply and
Maintenance
— 8 —
• Hospital
• Clinic
• Healthcare Center
• Framework of Government Cooperation
Project Financing
The Whole Industry Chain of Export Project——Healthcare Infrastructure
Engineering
Procurement
Construction
Healthcare
Infrastructure’s
Equipment • Supply
• Installation
• Maintenance
• Medical
• Education
• Research
Hospital
Management
— 9 —
• Framework of Government Cooperation
Project Financing
Engineering
Procurement
Construction
• Supply
• Installation
• Maintenance
Products Plantation
Production
Base’s
Equipment
• Product
buyback
• Medical resources
• Iodine, licorice and mint
Medical Resource Plantation and Production Base
— 10 —
Completion Tests, Training and Operation Management
Construction and Equipment Installation
Project Financing
Feasibility Study
Equipment, Primary Design and Engineering
The Whole Industry Chain of Export Project——Service Process
— 11 —
Integrated
Implementation of
Overseas Project
1 Fully meet the
Pharmaceutical
and Healthcare
needs of the Project
2
Taking full
responsibility of
Project’s
quality 3 4
The Whole Industry Chain of Export Project——Management Concept
Construction-
Operation
Integration
— 12 — — 12 —
PHARMENGIN provides customers with technical services throughout
project master layout planning, feasibility study , engineering design , project construction supervision,
project construction management, EPC, as well as GMP validation consulting service.
PHARMENGIN has accomplished more than 6,000 projects covering
consulting, engineering and construction. Pharmengin has been cooperating with dozens of international
companies including Pfizer, Astra Zeneca, Sagent, Fresenius-Kabi, AJINOMOTO, Otsuka, John Brown,
Bayer, Foster Wheeler and M+W.
PHARMENGIN has more than 80 items that honored by National, Provincial and Ministry in the categories of engineering consulting, engineering and science and technology progressing.
PHARMENGIN is the first company which is authorized the all three
certifications of Quality, Environmental, Health & Safety system (QEHS)among domestic pharmaceutical engineering companies.
Achievements
Sinopharm International —— Unique Advantage
Excellent Quality
Rich Experience
Service Provider
— 13 —
Equipment supply Staff training
Medical staff training
Maintenance
Amount： $61.79 million
Source of fund ： Chinese loan
Project Scope ： More than 120 hospitals and medical centers.
Project content ： Including 39 products, such as imaging, radiology, anesthesia, br
eathing ECG and medical furniture and other five categories
Project Name： Ecuador “National Public of Medical and Healthcare Institutions
Procurement of Medical Equipment and Installation and
Operating--use of People's Republic of China loan"
Installation and Testing
The Whole Industry Chain of Export Project——Successful Project
4S Center for Extension Services :
Component
Consumables, Maintenance
— 14 —
Co-founded by Sinopharm International and
Vietnamese enterprises in 2003, VCP is the first joint venture
between China and Vietnam, and the only overseas
manufacturing enterprise of Sinopharm Group.
VCP’s products include antibiotic powder-injection,
penicillin and cephalosporin with designed annual capacity of
100 million vials. With GMP/GSP/GLP/ISO 9001:2000
certificates, VCP is Vietnam’s first modernized powder-
injection manufacturer that complies with GMP standards of
WHO.
Integrated Overseas Project——Joint Venture Project
— 15 —
Pharmaceutical
Products
Medical
Instruments and
Apparatus
Export
Import
Medical Raw
Materials
Biological
Products
Drugs and
Preparations
Intermediates
Plant Extract
Medical Raw
Materials
Healthy Food Raw Materials
Export
Medical
Devices
Imported
Medical
Equipment
International Pharmaceutical Trade
— 16 —
Major Suppliers
Export Medical
Devices
Imported Medical
Equipment
Leading
Integrated
Supplier
Full Product Line
Professional
Training
4S service
center
Global Sales
network
Medical Instruments and Apparatus
— 17 —
International Medical Cooperation
By the end of Jun 2015, Our company has
organized 12 official seminars on
Pharmaceutical and Vaccine Investment and
Cooperation for developing countries. 198
officials from 53 countries/regions/international
Organizations participated these seminars.
— 18 —
61,000 Cases
of Surgeries
例
116,000 Person-times
of hospitalized patients
7 Hospitals
2,117,000 Person-times of both outpatients and
patients for emergency treatment
4000 Open Beds
12 Hospital Unions Sinopharm
Midland
Hospital
Management
Co., Ltd.
According to the statistics in 2015
Medical and Healthcare Services
Professional team of medical personnel
Sinopharm’s Tertiary A Hospitals
— 19 —
WORK IN PROGRESS BUILDING AREA (10000 Square meters)
INVESTMENT （Million）
Xinxiang East Hospital 28.35 $417
Xinxiang Maternal and Child Hospital 16.81
Xinxiang General Outpatient and Emergency Hospital 7.99 $69
Xinxiang General Practitioner Clinical Training Base 1.08 $7.5
Xinxiang General Burn Treatment Center 1.27 $8.8
Xinxiang Maternal and Child Hospital Xinxiang General Burn Treatment Center Xinxiang General Outpatient and
Emergency Hospital
Xinxiang
General Practitione
r Clinical Training
Base
Construction of Medical and Healthcare Services
— 20 —
Regional Hospital Management
Customer Base in
Health Industry
Sales Platform
Regional Hospital Management Company Manufacturers Suppliers
Information
Flow logistics
Cash
Flow
Knowledge
Flow
Business
Flow
Storage and logistics of
Medicine
Joint Provision from Rear
Services
Supply and Maintenance
of Instruments
Information System for
Hospital Management
Medical Cosmetology
Health Management
Medical Rehabilitation
中国国际医药卫生公司 China Sinopharm International Corporation
THANK YOU
Fu Qiang: Chief Engineer
Overseas Project II Department General Manager
Tel：（8610）84663501
Mobile:+8613901108262
Fax：（8610）84663190
E-mail：[email protected]
Gao Jianjun: Overseas Project II Department Project
Manager
Tel: (8610)84663818
Mobile:+ 8613241320918
Fax:(8610) 84663190
E-mail: [email protected]
